Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. Several removal methods are available, including freezing ...

Please provide your email address to receive an email when new articles are posted on . More photodynamic therapy (PDT) sessions were performed during winter vs. summer. Southern states saw the least ...

If you're like us, any time you notice a change in your skin you can get a little anxious—especially when it comes in the form of brown raised growths. But before you go down a worry rabbit hole, find ...

What Are Actinic Keratoses? Actinic keratoses (AKs) are a common skin condition characterized by rough, red, scaly patches, crusts, or sores on the top layer of skin (see Figures 1 & 2). If left ...

What's new concerning our understanding of actinic keratosis? Find out in this easy-to-navigate collection of recent MEDLINE abstracts compiled by the editors at Medscape Dermatology. Imiquimod 5% ...

Please provide your email address to receive an email when new articles are posted on . “As there is a risk of 0.025% to 16% per year for each actinic keratosis to progress to skin cancer, and it is ...

Our 'spotlight on' this month looks into the skin condition, actinic keratosis (also known as sunspots), which are premalignant but can develop into skin cancer. Kantar Health's Amy Sangway and ...

US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical gel 10% for treating ...

Sixty-five histologically confirmed acanthotic seborrheic keratoses of 65 individuals (33 men and 32 women) were retrieved from the histology files of the Department of Dermatology, University of ...

Expert advice from Dr Zoe Williams, our resident specialist and NHS GP Q: AN seborrheic keratoses give you back ache? My back is covered in it and I’m getting pain from about where my lungs are up to ...

(RTTNews) - Biofrontera Inc. (BFRI), Tuesday announced the completion of patient enrollment in its Phase 3 clinical trial for Ameluz or aminolaevulinic acid hydrochloride topical gel, 10 percent, for ...